TherapeuticsMD, Inc.
TherapeuticsMD, Inc. (TXMD) Stock Overview
Explore TherapeuticsMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
23.1M
P/E Ratio
-40.66
EPS (TTM)
$-0.06
ROE
-0.02%
TXMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of TherapeuticsMD, Inc. (TXMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 33.34, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $1.48.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -40.66 and a market capitalization of 23.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.